The trajectory of the erectile dysfunction drug presents a intricate picture for those considering investment. While the initial release generated substantial returns, the expiration of its intellectual property https://doctorbookmark.com/story21700272/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment